Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 6 of 6 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ADRA2A
💬1. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬1. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬1. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ADRA2B
💬2. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬2. ADRA2B
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬2. ADRA2B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ADRA2C
💬3. ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬3. ADRA2C
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬3. ADRA2C
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
PTGS2
💬4. PTGS2
| 22件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer 22件: Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling p ... | Celecoxib
Celecoxib
💬4. PTGS2
| Celecoxib | 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 💬4. PTGS2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
SLC6A2
💬5. SLC6A2
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle | Bupropion
Bupropion
💬5. SLC6A2
| Bupropion | 5件: 8 8, 18, 21, 96, 171 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
SLC6A3
💬6. SLC6A3
| 7件: Synaptic vesicle cycle Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism 7件: Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - ... | Bupropion
Bupropion
💬6. SLC6A3
| Bupropion | 5件: 8 8, 18, 21, 96, 171 💬
|